I am assuming that I just ran across the method used for remote targeting of designer drugs and a multitude of other garbage shot into us. I guess this is how my mother, at age 84 and after just mentioning to me that she had a family history of rh arthritis, seven weeks later was diagnosed with the disease. I'm sure there's also a good reason why in the early a.m. hours my nasal passages are clipped closed with forced breathing through mouth.
Tuesday, July 13, 2010
Business > Companies > BioDelivery Sciences International Inc.
Volume
19.8K
Change
+0.0799 +3.47%
Last
$2.38
07/13/2010 9:55 AM ET
BioDelivery Sciences International Inc.
BDSI: Nasdaq; Healthcare/Pharmaceuticals - Diversified
Company Information
BioDelivery Sciences International, Inc. (BDSI) is a specialty pharmaceutical company utilizing licensed and owned drug delivery technologies to develop
and commercialize, either on its own or in partnerships with third
parties, new formulations of therapeutics. The drug delivery
technologies include the BioErodible MucoAdhesive (BEMA) technology,
a small, erodible polymer film for application to the buccal mucosa
(the lining inside the cheek), and the Bioral cochleate drug delivery
technology, designed for the oral delivery of a range of products
otherwise administered intravenously. The Company's United States
Food and Drug Administration (FDA) product, ONSOLIS (fentanyl buccal
soluble film), as well as the developmental stage products, utilizes
the BEMA technology. The Bioral formulation is an encochleated
version of Amphotericin B, a treatment for fungal infections.
BioDelivery Sciences International Inc.
Web site
Comments